99-24366. Advisory Committee on Immunization Practices: Meeting  

  • [Federal Register Volume 64, Number 181 (Monday, September 20, 1999)]
    [Notices]
    [Pages 50818-50819]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-24366]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    
    
    Advisory Committee on Immunization Practices: Meeting
    
        In accordance with section 10(a)(2) of the Federal Advisory 
    Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
    Prevention (CDC) announces the following committee meeting:
    
        Name: Advisory Committee on Immunization Practices (ACIP).
        Times and Dates: 8 a.m.-6 p.m., October 20, 1999; 8 a.m.-6 p.m., 
    October 21, 1999; 8 a.m.-12 p.m., October 22, 1999.
        Place: Auditorium B, Centers for Disease Control and Prevention, 
    1600 Clifton Road, N.E., Atlanta, Georgia 30333.
    
    [[Page 50819]]
    
        Status: Open to the public, limited only by the space available.
        Purpose: The Committee is charged with advising the Director, 
    CDC, on the appropriate uses of immunizing agents. In addition, 
    under 42 U.S.C. 1396s, the Committee is mandated to establish and 
    periodically review and, as appropriate, revise the list of vaccines 
    for administration to vaccine-eligible children through the Vaccines 
    for Children (VFC) program, along with schedules regarding the 
    appropriate periodicity, dosage, and contraindications applicable to 
    the vaccines.
        Matters To Be Discussed: The agenda will include a review of 
    issues relating to the goal of eliminating or reducing the 
    thimerosal content of vaccines; adoption of the harmonized 
    immunization schedule for the year 2000; recommendations for use of 
    meningococcal polysaccharide vaccine for college students; an update 
    on the use of meningococcal conjugate vaccine in the United Kingdom; 
    recommendations for use of pneumococcal conjugate vaccine; inclusion 
    of the pneumococcal vaccine in the Vaccines for Children program; 
    recommendations for use of neuraminidase inhibitors; use of 
    influenza vaccine in pregnant women and young children; plans to 
    revise the adult immunization recommendations; approval of standing 
    orders for adult immunization, adolescent/adults acellular pertussis 
    products; adverse events reported after use of yellow fever vaccine 
    in older adults; prevention of pneumococcal disease in adults <65 years="" old;="" an="" update="" on="" the="" bioterrorism="" work="" group;="" military="" experience="" on="" use="" of="" anthrax="" vaccine;="" an="" update="" from="" the="" food="" and="" drug="" administration;="" update="" from="" the="" national="" center="" for="" infectious="" diseases;="" update="" from="" the="" national="" immunization="" program;="" update="" from="" the="" vaccine="" injury="" compensation="" program;="" update="" from="" the="" national="" vaccine="" program;="" rotavirus="" vaccine="" and="" intussusception;="" and="" resumption="" or="" continued="" suspension="" of="" use="" of="" rotavirus="" vaccine.="" other="" matters="" of="" relevance="" among="" the="" committee's="" objectives="" may="" be="" discussed.="" agenda="" items="" are="" subject="" to="" change="" as="" priorities="" dictate.="" contact="" person="" for="" more="" information:="" john="" r.="" livengood,="" m.d.,="" director,="" epidemiology="" and="" surveillance="" division,="" national="" immunization="" program,="" cdc,="" cdc,="" 1600="" clifton="" road,="" ne,="" m/s="" e61,="" atlanta,="" georgia="" 30333.="" telephone="" 404/639-8254.="" the="" director,="" management="" analysis="" and="" services="" office="" has="" been="" delegated="" the="" authority="" to="" sign="" federal="" register="" notices="" pertaining="" to="" announcements="" of="" meetings="" and="" other="" committee="" management="" activities="" for="" both="" the="" centers="" for="" disease="" control="" and="" prevention="" and="" the="" agency="" for="" toxic="" substances="" and="" disease="" registry.="" dated:="" september="" 14,="" 1999.="" john="" c.="" burckhardt,="" acting="" director,="" management="" analysis="" and="" services="" office,="" centers="" for="" disease="" control="" and="" prevention.="" [fr="" doc.="" 99-24366="" filed="" 9-17-99;="" 8:45="" am]="" billing="" code="" 4163-18-p="">

Document Information

Published:
09/20/1999
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
99-24366
Dates:
8 a.m.-6 p.m., October 20, 1999; 8 a.m.-6 p.m., October 21, 1999; 8 a.m.-12 p.m., October 22, 1999.
Pages:
50818-50819 (2 pages)
PDF File:
99-24366.pdf